Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
20.15B
Market cap20.15B
Price-Earnings ratio
21.24
Price-Earnings ratio21.24
Dividend yield
1.74%
Dividend yield1.74%
Average volume
1.18M
Average volume1.18M
High today
$182.44
High today$182.44
Low today
$179.73
Low today$179.73
Open price
$182.44
Open price$182.44
Volume
830.62K
Volume830.62K
52 Week high
$197.55
52 Week high$197.55
52 Week low
$150.99
52 Week low$150.99

Stock Snapshot

As of today, Quest Diagnostics(DGX) shares are valued at $181.02. The company's market cap stands at 20.15B, with a P/E ratio of 21.24 and a dividend yield of 1.7%.

During the trading session on 2026-01-25, Quest Diagnostics(DGX) shares reached a daily high of $182.44 and a low of $179.73. At a current price of $181.02, the stock is +0.7% higher than the low and still -0.8% under the high.

Trading volume for Quest Diagnostics(DGX) stock has reached 830.62K, versus its average volume of 1.18M.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $150.99.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $150.99.

DGX News

Simply Wall St 3d
Quest Diagnostics Reputation And At-Home Testing Efforts Catch Investor Attention

Quest Diagnostics (NYSE:DGX) has been named to the Fortune 2026 World's Most Admired Companies list, ranking number two in its industry category. The company i...

Quest Diagnostics Reputation And At-Home Testing Efforts Catch Investor Attention
Simply Wall St 5d
Quest Diagnostics Expands At Home STI Testing As Valuation Signals Upside Potential

Quest Diagnostics (NYSE:DGX) has partnered with Visby Medical to offer an at-home, FDA authorized PCR test focused on women's sexual health. The new test targe...

Quest Diagnostics Expands At Home STI Testing As Valuation Signals Upside Potential

Analyst ratings

55%

of 22 ratings
Buy
40.9%
Hold
54.5%
Sell
4.5%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.